1. Acknowledgement to Referees

   Acknowledgement to Referees 11 November 2016 Pages: 485 - 487

2. Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

   • Ira Jacobs
   • Danielle Petersel
   • Sadiq Lula

   Systematic Review Open access 02 November 2016 Pages: 489 - 523

   

3. Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

   • Ira Jacobs
   • Danielle Petersel
   • K. Lea Sewell

   Systematic Review Open access 25 November 2016 Pages: 525 - 570

   

4. Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors

   • Daphne Day
   • Aaron R. Hansen

   Review article 15 November 2016 Pages: 571 - 584

   

5. Rheumatologists’ Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey

   • Morgane Beck
   • Bruno Michel
   • On behalf of the CRI (Club “Rhumatismes et Inflammations”)

   Original Research Article 15 November 2016 Pages: 585 - 592

   

6. Identification of Potential Therapeutics to Conquer Drug Resistance in Salmonella typhimurium: Drug Repurposing Strategy

   • Balasundaram Preethi
   • Veerappapillai Shanthi
   • Karuppasamy Ramanathan

   Original Research Article 19 October 2016 Pages: 593 - 605

   

7. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases

   • Emma D. Deeks

   Adis Drug Evaluation 04 October 2016 Pages: 607 - 617